Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Find effective ways to increase your credit card rewards. Maximize your benefits and enjoy more perks!
13,973 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
Bitcoin faces renewed scrutiny as gold climbs and crypto markets wobble in early 2026, challenging the widely watched...
As 2026 unfolds, a new government analysis finds that majors tied to real-world demand offer strong pay and job stabi...
Looking for tech stocks with staying power? This guide breaks down how to pick what best tech stocks to hold for the ...
In close CEO searches, the runner-up often lands a multi-million retention package. This trend shows up in Disney, Mo...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...
Bold claims about doubling your money tempt investors. This guide explains realistic paths to potential outsized gain...
As Ranpak tackles 2025 earnings, investors watch for sustainable packaging demand, margin discipline, and cash flow r...
At the dawn of 2026, rental demand isn’t following the usual big-city script. Cities like Cincinnati, Atlanta, and Mi...